You are here

Arrowhead

As Arrowhead falters, lungs remain a tough target for RNA drugs

BioPharma Dive

Wed, 07/7/21 - 11:00 am

cystic fibrosis

Johnson & Johnson pays $175M, commits to $1.6B in milestones for Arrowhead hepatitis B drug

Fierce Biotech

Thu, 10/4/18 - 10:22 am

3 Biotech Stocks That Soared This Week

Motley Fool

Sat, 05/12/18 - 01:10 pm

ARMO BioSciences

Monday’s 4 Biggest Biopharma Movers

Yahoo/24-7 Wall St

Mon, 01/9/17 - 06:39 pm

Merrimack Pharmaceuticals

7 of the Most Shocking Biotech Pipeline Blowups of 2016

Motley Fool

Sun, 12/4/16 - 12:37 pm

Clovis Oncology

Celldex Therapeutics

Arrowhead spanked with clinical hold in hep B

BioPharma Dive

Thu, 11/10/16 - 04:10 pm

Amgen and Arrowhead to develop gene-therapies for heart disease

Yahoo/Reuters

Thu, 09/29/16 - 08:18 am

Arrowhead Research purchases privately held Alvos Therapeutics

Yahoo/AP

Wed, 04/11/12 - 10:58 am

Alvos Therapeutics

Arrowhead unit to collaborate with Smith & Nephew

Tue, 10/19/10 - 07:28 am

cartilage regeneration